Skip to main content
. 2017 Nov 15;15(1):795–802. doi: 10.3892/ol.2017.7428

Figure 2.

Figure 2.

EMAF and NSCLC patients' overall survival. Survival curves for the discovery set (A) and replication set (B) cases, which were divided into low-EMAF (red) and high-EMAF (blue) groups by the median value. Hazard ratios (HRadjust) and P-values were estimated by Cox regression with adjustment for age, gender, smoking status, clinical stage, T classification, N classification and histology type l.